期刊文献+

难治性强迫障碍患者认知功能和血浆C反应蛋白水平的关联

Association of cognitive function,plasma C-reactive protein level in patients with treatment-resistant obsessive-compulsive disorder
下载PDF
导出
摘要 目的:分析难治性强迫障碍(trOCD)患者的认知功能、临床症状与血浆C-反应蛋白(CRP)水平的关系。方法:纳入55例trOCD和45例非难治强迫障碍(non-trOCD)患者及65名正常对照。采用Yale-Brown强迫量表、汉密顿抑郁量表(HAMD)、汉密顿焦虑量表(HAMA)、MATRICS共识认知成套测验(MCCB)等评估强迫、抑郁焦虑症状和认知功能,以免疫胶乳比浊法检测被试血浆CRP水平。结果:与其他组相比,trOCD组MCCB总分及信息处理速度、工作记忆、推理及问题解决能力较低,血浆CRP水平和高CRP患者比例(≥3 mg/L)较高(均P<0.05);non-trOCD不同CRP组间MCCB各维度差异无统计学意义(均P>0.05)。Logistic回归分析显示,难治性风险因素有强迫症状多(OR=2.01)、严重程度高(OR=2.29)、MCCB总分低(OR=4.01)、血浆CRP水平高(OR=4.24)、病程长(OR=3.23)(P<0.05)。结论:trOCD患者认知功能下降、血浆CRP水平升高,与强迫症状多、严重程度高和病程长关联。 Objective:To evaluate the association of cognitive function,clinical symptoms,and plasma C-reac-tive protein(CRP)level in patients with treatment-resistant obsessive-compulsive disorder(trOCD).Methods:Fif-ty-five patients with trOCD,45 patients with non-trOCD,and 65 normal controls were enrolled.The Yale-Brown Obsessive-Compulsive Scale(YBOCS),Hamilton depression scale,Hamilton anxiety scale,MATRICS Consensus Cognitive Battery(MCCB)were used to evaluate the OCD,depressive or anxious clinical symptoms,as well as cognitive function,in above-mentioned subjects.The plasma CRP level were examined by using the latex-enhanced immunoturbidimetry methods in three groups.Results:Compared with the other two groups,the MCCB cognition scores,especially information processing speed,working memory,inferential knowledge and problem-solving skills were higher in the trOCD group,respectively(Ps<0.05).The plasma CRP level and percentage of cases with high CRP level(≥3 mg/L)in the trCOD group were higher than those in other two groups(P<0.05).However,difference of MCCB and its factorial scores revealed no statistical significances in non-trOCD group(Ps>0.05).Logistic regression analysis showed that potential risk factors of treatment-resistant OCD including,more obsessive-compulsive symptoms(OR=2.01),higher severity of OCD(OR=2.29),lower MCCB total scores(OR=4.01),higher plasma CRP level(OR=4.24),and longer disease course of OCD(OR=3.23)(P<0.05).Conclusion:Impaired cognitive function,high plasma C-reactive protein level,may be associated with more obsessive-compul-sive symptoms,higher severity of OCD,as well as long disease course of OCD.
作者 夏舜尧 魏贵明 石川 岳伟华 迟锐 XIA Shunyao;WEI Guiming;SHI Chuan;YUE Weihua;CHI Rui(Peking University Sixth Hospital,Peking University Institute of Mental Health,NHC Key Laboratory of Mental Health(Peking U-niversity),National Clinical Research Center for Mental Disorders(Peking University Sixth Hospital),Beijing 100083,China;Daizhuang Hospital of Shandong Province,Jining 272051,Shandong Province,China)
出处 《中国心理卫生杂志》 CSCD 北大核心 2023年第12期1031-1037,共7页 Chinese Mental Health Journal
基金 北京市脑计划(Z161100000216139) 国家自然科学基金(81825009)。
关键词 难治性强迫障碍 认知功能 C-反应蛋白 抑郁症状 焦虑症状 treatment-resistant obsessive-compulsive disorder(trOCD) cognitive function C-reactive pro-tein(CRP) depressive symptom anxiety symptom
  • 相关文献

参考文献4

二级参考文献27

  • 1[1]Spiegel EA, Wycis HT. Physiological and psychological results of thalamotomy. Proc RSCc Med, 1949,42(1):89.
  • 2[2]Talairach J, Hecaen H, David M, et al. Recherehes sur la coagulation therapeutique des structnres sous-corticales chez 1'homme. Rev Neruol (Paris), 1949,81(1):4.
  • 3[3]Leksell L. A stereotaxic apparatus for intracerebral surgery. Acta Chirurg Scand, 1949,99(3): 229.
  • 4[4]Leksell L. Stereotaxis and Radiosurgery. Springfield, IL: Thomas,1971.
  • 5[5]Modell JG, Mountz JM, Curtis GC, et al. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechamism of obsessive-compulsive disorder. Clin Neurosci,1989,1(1 ) :27.
  • 6[6]Malloy P. Frontal lobe dysfuntion in OCD. in Perecman E (ed). The Frontal Lobes Revisited. New York: IRBN Press, 1987. 207 - 223.
  • 7[7]Baxter L Jr, Schwartz J, Mazziotta, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry, 1988, 145(12):1560.
  • 8[8]Sawle G, Hymas N, Less A, et al. Obsessional slowness: Functional studies with position emission tomography. Brain, 1991, 114(10) :2191.
  • 9[9]Baxter LR Jr, Schwartz JM, Bergmann KS, et al. Caudate glucose metabolic rate changes with both drug and behaviors therapy for obsessive-compulsive disorder. Arch Gen Psychiatry, 1992, 49(9) :681.
  • 10[10]Brody AL, Saxena S, Schwartz JM, et al. FDG-PET predictors of response to behavioral therapy and pharmcotherapy in obsessive compulsive disorder. Psychiatry Res, 1998, 84( 1 ): 1.

共引文献169

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部